- Home
- OFS vs BTMD Comparison
OFS vs BTMD Comparison
Compare OFS & BTMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OFS
- BTMD
- Stock Information
- Founded
- OFS 2001
- BTMD 2012
- Country
- OFS United States
- BTMD United States
- Employees
- OFS N/A
- BTMD N/A
- Industry
- OFS Finance/Investors Services
- BTMD Medicinal Chemicals and Botanical Products
- Sector
- OFS Finance
- BTMD Health Care
- Exchange
- OFS Nasdaq
- BTMD Nasdaq
- Market Cap
- OFS 110.3M
- BTMD 102.3M
- IPO Year
- OFS 2012
- BTMD N/A
- Fundamental
- Price
- OFS $8.75
- BTMD $4.10
- Analyst Decision
- OFS
- BTMD Strong Buy
- Analyst Count
- OFS 0
- BTMD 1
- Target Price
- OFS N/A
- BTMD $8.00
- AVG Volume (30 Days)
- OFS 38.5K
- BTMD 182.3K
- Earning Date
- OFS 05-01-2025
- BTMD 05-07-2025
- Dividend Yield
- OFS 15.40%
- BTMD N/A
- EPS Growth
- OFS N/A
- BTMD 201.68
- EPS
- OFS 2.25
- BTMD 0.60
- Revenue
- OFS $44,026,000.00
- BTMD $199,379,000.00
- Revenue This Year
- OFS N/A
- BTMD $5.93
- Revenue Next Year
- OFS N/A
- BTMD $9.07
- P/E Ratio
- OFS $3.92
- BTMD $6.87
- Revenue Growth
- OFS N/A
- BTMD 6.44
- 52 Week Low
- OFS $7.75
- BTMD $3.04
- 52 Week High
- OFS $10.04
- BTMD $8.44
- Technical
- Relative Strength Index (RSI)
- OFS 52.84
- BTMD 63.35
- Support Level
- OFS $8.53
- BTMD $3.85
- Resistance Level
- OFS $9.00
- BTMD $4.40
- Average True Range (ATR)
- OFS 0.34
- BTMD 0.25
- MACD
- OFS 0.02
- BTMD 0.09
- Stochastic Oscillator
- OFS 38.46
- BTMD 76.00
About OFS OFS Capital Corporation
OFS Capital Corp is an externally managed, closed-end, non-diversified management investment company. Its business objective is to generate current income and capital appreciation by investing in middle-market companies in the United States. The company focuses on investments in senior secured loans, including first lien, second lien, and unitranche loans, as well as subordinated loans and, to a lesser extent, warrants, and other equity securities.
About BTMD Biote Corp.
Biote Corp operates a growth practice-building business within the hormone optimization space. It provides the necessary components to enable Biote-certified practitioners to establish, build, and successfully implement a program designed to optimize hormone levels using personalized solutions for their patient populations. The company derives revenue from United States and also has its presence in other countries.